An FDA advisory committee on Wednesday voted 18-0 to recommend more flexibility for the agency-sponsored iPledge program, which aims to prevent pregnancies among women using the acne drug isotretinoin, the Wall Street Journal reports. [click link for full article]
From: www.medicalnewstoday.com
FDA Advisory Panel Recommends Making Accutane IPledge Program More Flexible
Posted by Ruslan Abuzant at 11:56 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment